Newman Dignan & Sheerar Inc.’s holdings in SPDR S&P Biotech ETF were worth $712,000 as of its most recent filing with the SEC. Get SPDR S&P Biotech ETF alerts:SPDR S&P Biotech ETF Stock PerformanceShares of NYSEARCA:XBI opened at $101.39 on Thursday. About SPDR S&P Biotech ETFSPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report). Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.